Irritable and Inflammatory Bowel Diseases and the Pancreatic Cancer

T10DQ1 Student Name Instructor Name Institutional Affiliation Course Number and Name Due Date Question 1 Irritable bowel syndrome (IBS) and inflammatory bowel syndrome (IBD) vary. For instance, IBS illustrates a higher frequency of disordered defecation, abdominal discomfort or pain, and diverse bowel habit trait subtypes (Barbara et al., 2014). However, IBD only has two primary clinical variations, including Chron’s disease and ulcerative colitis, with their main symptoms being diarrhea, intestinal pain, and blood-stained stool. The two conditions differ regarding microbiota composition because evidence illustrates diminished diversity and different intestinal microbiota compositions in IBD compared to patients with IBS (Barbara et al., 2014). Barbara, et al. (2014) also indicate that the prevalence rates for IBD are approximately 1.5 – 294 individuals for every 100,000. IBS far-outmatches this rate because it presents a frequency of about 10 – 20% (Barbara et al., 2014). Other differences include that while IBD patients seek healthcare intervention, IBS does not. Further evidence indicates that IBD affects inpatient and outpatient care while IBS primarily occurs in outpatient. Question 2 Pancreatic cancer is one of the gastrointestinal cancers of ...